Studies on bacterial cellulose/poly vinyl alcohol (BC/PVA) hydrogel composites as tissue-engineered corneal stroma.
Corneal transplantation remains solely, the current major solution in the treatment of severe corneal diseases. However, it faces a restriction due to the limitation of corneal donors. The tissue-engineered cornea is a potential substitution in this area that can help to avert this limitation. The present research envisages the development of a novel tissue-engineered corneal stroma consisting of bacterial cellulose/poly vinyl alcohol (BC/PVA) hydrogel composites for reconstructing the cornea. It was found that the properties of BC/PVA exhibited a better suitability for its use as a corneal stroma material compared to the bacterial cellulose (BC) hydrogel. The human corneal stromal cells (hCSCs) were used to evaluate the cytotoxicity of the materials, wherein BC/PVA displayed excellent biocompatibility with these cells. Furthermore, in the in-vivo studies, the BC/PVA was transplanted intrastromally in rabbits. After 4 weeks, the cornea remained almost transparent, and without obvious inflammation, sensitization or neovascularization as confirmed by the clinical and histological examination. Our results demonstrate that BC/PVA was well-tolerated in the rabbit cornea, and may be a potential substitute for corneal stroma.